BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 33175608)

  • 1. Identification of potential lipid biomarkers for active pulmonary tuberculosis using ultra-high-performance liquid chromatography-tandem mass spectrometry.
    Han YS; Chen JX; Li ZB; Chen J; Yi WJ; Huang H; Wei LL; Jiang TT; Li JC
    Exp Biol Med (Maywood); 2021 Feb; 246(4):387-399. PubMed ID: 33175608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening and identification of potential novel lipid biomarkers for non-small cell lung cancer using ultra-high performance liquid chromatography tandem mass spectrometry.
    Han YS; Shi LY; Chen JX; Chen J; Li ZB; Lu QQ; Zhang SQ; Liu J; Yi WJ; Jiang TT; Li JC; Huang J
    Anat Rec (Hoboken); 2022 May; 305(5):1087-1099. PubMed ID: 34347376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of Lipid Metabolism Alterations in Children with Active Tuberculosis Using UHPLC-MS/MS.
    Sun B; Liu F; Yin Q; Jiang T; Fang M; Duan L; Quan S; Tian X; Shen A; Mi K; Sun L
    J Immunol Res; 2023; 2023():8111355. PubMed ID: 36815950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapeutic evaluation biomarkers of lipid metabolism targets in uncomplicated pulmonary tuberculosis patients.
    Chen JX; Han YS; Zhang SQ; Li ZB; Chen J; Yi WJ; Huang H; Jiang TT; Li JC
    Signal Transduct Target Ther; 2021 Jan; 6(1):22. PubMed ID: 33462176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic Profiling of Plasma from Patients with Tuberculosis by Use of Untargeted Mass Spectrometry Reveals Novel Biomarkers for Diagnosis.
    Lau SK; Lee KC; Curreem SO; Chow WN; To KK; Hung IF; Ho DT; Sridhar S; Li IW; Ding VS; Koo EW; Wong CF; Tam S; Lam CW; Yuen KY; Woo PC
    J Clin Microbiol; 2015 Dec; 53(12):3750-9. PubMed ID: 26378277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid metabolism analysis for peripheral blood in patients with alcohol
    Yan Y; Yu Y; Liu J; Zhao H; Wang J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 47(7):872-880. PubMed ID: 36039583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of lipid biomarker from serum in patients with chronic obstructive pulmonary disease.
    Liu D; Meister M; Zhang S; Vong CI; Wang S; Fang R; Li L; Wang PG; Massion P; Ji X
    Respir Res; 2020 Sep; 21(1):242. PubMed ID: 32957957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of serum metabolic profile by ultra-performance liquid chromatography-mass spectrometry for biomarkers discovery: application in a pilot study to discriminate patients with tuberculosis.
    Feng S; Du YQ; Zhang L; Zhang L; Feng RR; Liu SY
    Chin Med J (Engl); 2015 Jan; 128(2):159-68. PubMed ID: 25591556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma metabolites Xanthine, 4-Pyridoxate, and d-glutamic acid as novel potential biomarkers for pulmonary tuberculosis.
    Huang H; Shi LY; Wei LL; Han YS; Yi WJ; Pan ZW; Jiang TT; Chen J; Tu HH; Li ZB; Hu YT; Li JC
    Clin Chim Acta; 2019 Nov; 498():135-142. PubMed ID: 31442449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host lipidome and tuberculosis treatment failure.
    Shivakoti R; Newman JW; Hanna LE; Queiroz ATL; Borkowski K; Gupte AN; Paradkar M; Satyamurthi P; Kulkarni V; Selva M; Pradhan N; Shivakumar SVBY; Natarajan S; Karunaianantham R; Gupte N; Thiruvengadam K; Fiehn O; Bharadwaj R; Kagal A; Gaikwad S; Sangle S; Golub JE; Andrade BB; Mave V; Gupta A; Padmapriyadarsini C
    Eur Respir J; 2022 Jan; 59(1):. PubMed ID: 34375300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum amyloid A, protein Z, and C4b-binding protein β chain as new potential biomarkers for pulmonary tuberculosis.
    Jiang TT; Shi LY; Wei LL; Li X; Yang S; Wang C; Liu CM; Chen ZL; Tu HH; Li ZJ; Li JC
    PLoS One; 2017; 12(3):e0173304. PubMed ID: 28278182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A serum lipidomic strategy revealed potential lipid biomarkers for early-stage cervical cancer.
    Cheng F; Wen Z; Feng X; Wang X; Chen Y
    Life Sci; 2020 Nov; 260():118489. PubMed ID: 32976882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining metabolome and clinical indicators with machine learning provides some promising diagnostic markers to precisely detect smear-positive/negative pulmonary tuberculosis.
    Hu X; Wang J; Ju Y; Zhang X; Qimanguli W; Li C; Yue L; Tuohetaerbaike B; Li Y; Wen H; Zhang W; Chen C; Yang Y; Wang J; Chen F
    BMC Infect Dis; 2022 Aug; 22(1):707. PubMed ID: 36008772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid metabolism and identification of biomarkers in asthma by lipidomic analysis.
    Jiang T; Dai L; Li P; Zhao J; Wang X; An L; Liu M; Wu S; Wang Y; Peng Y; Sun D; Zheng C; Wang T; Wen X; Cheng Z
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Feb; 1866(2):158853. PubMed ID: 33160078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.
    Wang X; Guan X; Tong Y; Liang Y; Huang Z; Wen M; Luo J; Chen H; Yang S; She Z; Wei Z; Zhou Y; Qi Y; Zhu P; Nong Y; Zhang Q
    BMC Cancer; 2024 May; 24(1):644. PubMed ID: 38802800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution plasma metabolomics analysis to detect Mycobacterium tuberculosis-associated metabolites that distinguish active pulmonary tuberculosis in humans.
    Collins JM; Walker DI; Jones DP; Tukvadze N; Liu KH; Tran VT; Uppal K; Frediani JK; Easley KA; Shenvi N; Khadka M; Ortlund EA; Kempker RR; Blumberg HM; Ziegler TR
    PLoS One; 2018; 13(10):e0205398. PubMed ID: 30308073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics.
    Li W; Wang X; Zhang X; Gong P; Ding D; Wang N; Wang Z
    Lipids Health Dis; 2021 Nov; 20(1):160. PubMed ID: 34774030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood transcriptomic diagnosis of pulmonary and extrapulmonary tuberculosis.
    Roe JK; Thomas N; Gil E; Best K; Tsaliki E; Morris-Jones S; Stafford S; Simpson N; Witt KD; Chain B; Miller RF; Martineau A; Noursadeghi M
    JCI Insight; 2016 Oct; 1(16):e87238. PubMed ID: 27734027
    [No Abstract]   [Full Text] [Related]  

  • 19. UPLC-MS/MS-based plasma lipidomics reveal a distinctive signature in systemic lupus erythematosus patients.
    Chen J; Liu C; Ye S; Lu R; Zhu H; Xu J
    MedComm (2020); 2021 Jun; 2(2):269-278. PubMed ID: 34766146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and identification of serum potential biomarkers for pulmonary tuberculosis using iTRAQ-coupled two-dimensional LC-MS/MS.
    Xu DD; Deng DF; Li X; Wei LL; Li YY; Yang XY; Yu W; Wang C; Jiang TT; Li ZJ; Chen ZL; Zhang X; Liu JY; Ping ZP; Qiu YQ; Li JC
    Proteomics; 2014 Feb; 14(2-3):322-31. PubMed ID: 24339194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.